Diagnosis (Laboratory other parameters)

Aus coViki
Wechseln zu: Navigation, Suche


any

  • GET 2020. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Extract
  • GET 2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study Extract
  • GET 2020. Emerging key laboratory tests for patients with COVID-19 Extract
  • GET ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus Extract
  • GET 2020. Mild versus severe COVID-19: Laboratory markers Extract
  • GET ä. Retrospective analysis of laboratory testing in 54 patients with severe- or critical-type 2019 novel coronavirus pneumonia Extract
  • GET 2020. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation Extract
  • GET 2020. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests. Extract
  • GET 2020. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Extract
  • GET 2020. Circulating levels of IL-2, IL-4, TNF-alpha, IFN-gamma, and C-reactive protein are not associated with severity of COVID-19 symptoms. Extract
  • GET 2020. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room. Extract
  • GET 2020. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Extract


Hypoxia

  • GET 2020. Silent hypoxia: A harbinger of clinical deterioration in patients with COVID-19. Extract


Glucose

  • GET 2020. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes Extract
  • GET 2020. Glucovigilance in COVID-19. Extract


Presepsin

  • GET 2020. Presepsin in risk stratification of SARS-CoV-2 patients Extract
  • GET 2020. Presepsin as a predictive biomarker of severity in COVID-19: A case series. Extract


Procalcitonin

  • GET 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Extract
  • GET 2020. Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19. Extract
  • GET 2020. Procalcitonin levels in COVID-19 patients. Extract

SAA serum amyloid a

  • GET ä. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19) Extract


suPAR

  • GET 2020. Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia Extract

Fever

  • GET 2020. Body temperature correlates with mortality in COVID-19 patients. Extract
  • GET 2020. Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19. Extract
  • GET 2020. Hyperpyrexia in COVID-19 patients. Extract

ESR BKS BSG

  • GET 2020. Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis. Extract

CRP

  • GET ä. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study Extract
  • GET 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Extract
  • GET 2020. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early Extract
  • GET ä. C reactive protein level may predict the risk of COVID-19 aggravation Extract
  • GET 2020. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Extract
  • GET 2020. Prognostic value of C-reactive protein in patients with COVID-19. Extract
  • GET 2020. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. Extract
  • GET 2020. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. Extract
  • GET 2020. Plasma CRP level is positively associated with the severity of COVID-19. Extract
  • GET 2020. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Extract
  • GET 2020. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Extract


IL-6

  • GET 2020. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Extract
  • GET ä. Interleukin-6 as a potential biomarker of COVID-19 progression Extract
  • GET 2020. Interleukin-6 levels in children developing SARS-CoV-2 infection Extract
  • GET 2020. High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients Extract
  • GET 2020. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Extract
  • GET 2020. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. Extract
  • GET 2020. IL-6 may be a good biomarker for earlier detection of COVID-19 progression. Extract
  • GET 2020. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. Extract
  • GET 2020. Interleukin-6 as prognosticator in patients with COVID-19. Extract

IL-10

  • GET 2020. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Extract
  • GET 2020. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. Extract

IL-1ra

  • GET 2020. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. Extract

Rantes

  • GET 2020. Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. Extract

NLratio

  • GET ä. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 Extract
  • GET 2020. Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan Extract
  • GET 2020. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. Extract
  • GET ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients Extract
  • GET 2020. Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients. Extract
  • GET 2020. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Extract
  • GET 2020. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Extract
  • GET 2020. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19. Extract
  • GET 2020. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Extract

PLratio

  • GET 2020. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. Extract

Troponin

  • GET ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients? Extract

Eosinophils

GET ä. Eosinophil count in severe coronavirus disease 2019 (COVID-19) Extract
  • GET ä. Response letter to Eosinophil count in severe coronavirus disease 2019 (COVID-19) Extract

IL2R on lymphcytes

  • GET 2020. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19 Extract

Angiopoietin 2

  • GET 2020. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Extract

microRNA

  • GET 2020. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Extract

tumor markers

  • GET 2020. Elevations of serum cancer biomarkers correlate with severity of COVID-19 Extract

mda5 il-24

  • GET 2020. MDA5 should be detected in severe COVID-19 patients. Extract

H2S

  • GET 2020. Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Corona virus. Extract

ACE2

  • GET 2020. ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease. Extract

trmpss2

  • GET 2020. TMPRSS2: Potential Biomarker for COVID-19 Outcomes. Extract

KL-6

  • GET 2020. Serum KL-6 concentrations as a novel biomarker of severe COVID-19. Extract

monocyte distribution width

  • GET 2020. Elevated monocyte distribution width in COVID-19 patients: The contribution of the novel sepsis indicator. Extract

Calcium

  • GET 2020. Low levels of total and ionized calcium in blood of COVID-19 patients. Extract
  • GET 2020. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Extract

LDH

  • GET 2020. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients. Extract

Liver enzymes

  • GET 2020. Aspartate aminotransferase: A prognostic marker rather than a specific liver injury marker in COVID-19. Extract
  • GET 2020. Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19. Extract
  • GET 2020. An updated meta-analysis of AST and ALT levels and the mortality of COVID-19 patients. Extract

Albumen

  • GET 2020. Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. Extract
  • GET 2020. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Extract
  • GET 2020. Hypoalbuminaemia in COVID-19 infection: A predictor of severity or a potential therapeutic target? Extract
  • GET 2020. Is Albumin Predictor of Mortality in COVID-19? Extract


Urine

  • GET 2020. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19). Extract
  • GET 2020. The value of urine biochemical parameters in the prediction of the severity of coronavirus disease 2019 Extract

ER stress

  • GET 2020. Endoplasmic Reticulum Stress Markers in SARS-COV-2 Infection and Pneumonia: Case-Control Study. Extract

autoantibodies

  • GET 2020. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Extract

MetHemoglobinemia

  • GET 2020. The emergence of methemoglobinemia amidst the COVID-19 pandemic. Extract

profiling multiple parameters, reviews

  • GET ä. Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China Extract
  • GET 2020. The laboratory tests and host immunity of COVID-19 patients with different severity of illness Extract
  • GET 2020. Routine blood tests as a potential diagnostic tool for COVID-19 Extract
  • GET 2020. Laboratory abnormalities in patients with COVID-2019 infection Extract
  • GET 2020. Laboratory abnormalities in children with novel coronavirus disease 2019 Extract
GET 2020. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis Extract
  • GET ä. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID?19 Extract
  • GET ä. Elevated levels of plasma cytokines in COVID-19 reflect viral load and lung injury Extract
  • GET 2020. Association of viral load with serum biomakers among COVID-19 cases Extract
  • GET 2020. Biomarkers associated with COVID-19 disease progression. Extract
  • GET 2020. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Extract
  • GET 2020. Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Extract
  • GET 2020. Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients. Extract
  • GET 2020. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019. Extract


host genetics

GET 2020. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic. Extract
  • GET 2020. COVID-19 outcomes and the human genome. Extract
  • GET 2020. Genomic search for COVID-19 severity clues. Extract
  • GET 2020. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Extract
  • GET 2020. Effects of host genetic variations on response to, susceptibility and severity of respiratory infections. Extract
  • GET 2020. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection. Extract
  • GET 2020. Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes. Extract
  • GET 2020. Genetic predisposition models to COVID-19 infection Extract


blood groups

  • GET 2020. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome. Extract
  • GET 2020. COVID-19 and ABO blood group: another viewpoint. Extract
  • GET 2020. COVID-19 and the ABO blood group connection. Extract
  • GET 2020. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases Extract

HLA

  • GET 2020. Human leukocyte antigen susceptibility map for SARS-CoV-2 Extract
  • GET 2020. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19). Extract
  • GET 2020. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. Extract


apoE

  • GET 2020. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. Extract

on ace2, trmpss2

  • GET 2020. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits. Extract
  • GET 2020. Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations. Extract
  • GET 2020. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Extract


ace1

  • GET 2020. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Extract

complement

  • GET 2020. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Extract
  • GET 2020. C3 polymorphisms represent an important immunological confounder on the spread and outcome of COVID-19. Extract


cytokines

  • GET 2020. Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans. Extract

redox

  • GET 2020. An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge